HPLC METHOD DEVELOPMENT AND VALIDATION OF LERCANIDIPINE HCL AND ATENOLOL, CHARACTERIZATION OF ITS DEGRADANTS BY LC-MS/MS
DOI:
https://doi.org/10.22159/ijap.2022v14i2.43624Keywords:
Development, Validation, Lercanidipine , HCl, Atenolol, LC-MS/MSAbstract
Objective: An assay method was developed and validated for the simultaneous estimation of Lercanipine HCl and atenolol using RP-HPLC.
Methods: An effective chromatographic separation was achieved using waters symmetry C18 column of dimensions 150x4.6 mm, 3.5 μm, as a stationary phase. 0.1 percent ortho phosphoric acid and acetonitrile in 50:50 v/v was used as a mobile process with a rate of flow 1 ml/min and UV detection was carried out at 230 nm, respectively. Isocratic chromatography at ambient temperature was performed.
Results: Lercanidipine HCl and atenolol were separated by a running time of around 8 min. at 2.925 min. and 6.482 min. Respectively. By injecting the norm six times, device suitability parameters were studied and the outcomes were well under the acceptance criteria. The linearity analysis was performed at levels ranging from 10% to 150% and the R2 value was found to be 0.999.
Conclusion: Assay method validation was performed by using the marketed formulation and found to be within the limit. Degradation tests were conducted and the degradants were characterized by using LC-MS/MS.
Downloads
References
Whelton PK, Williams B. The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: More Similar Than Different. JAMA. 2018;320(17):1749-50. doi: 10.1001/jama.2018.16755, PMID 30398611.
Parekh N, Page A, Ali K, Davies K, Rajkumar C. A practical approach to the pharmacological management of hypertension in older people. Ther Adv Drug Saf. 2017;8(4):117-32. doi: 10.1177/2042098616682721, PMID 28439398.
Tekol Y. The medieval physician Avicenna used an herbal calcium channel blocker, taxus baccata L. Phytother Res. 2007;21(7):701-2. doi: 10.1002/ptr.2173, PMID 17533639.
Sica DA. Calcium channel blocker-related peripheral Edema: Can It Be Resolved? J Clin Hypertens. 2003;5(4):291-5. doi: 10.1111/j.1524-6175.2003.02402.x.
Barrios V, Escobar C, Navarro A, Barrios L, Navarro-Cid J, Calderon A, Laura Investigators. Lercanidipine is an effective and well-tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study. Int J Clin Pract. 2006;60(11):1364-70. doi: 10.1111/j.1742-1241.2006.01176.x, PMID 17073834.
Banks K, Lo M, Khera A. Angina in women without obstructive coronary artery disease. Curr Cardiol Rev. 2010;6(1):71-81. doi: 10.2174/157340310790231608, PMID 21286281.
Vaccarino V. Ischemic heart disease in women: many questions, few facts. Circ Cardiovasc Qual Outcomes. 2010;3(2):111-5. doi: 10.1161/CIRCOUTCOMES.109.925313, PMID 20160161.
Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD, Beta-Blockers in Heart Failure Collaborative Group. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual patient data meta-analysis. Lancet. 2014;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8, PMID 25193873.
Japp D, Shah A, Fisken S, Denvir M, Shenkin S, Japp A. Mineralocorticoid receptor antagonists in elderly patients with heart failure: a systematic review and meta-analysis. Age Ageing. 2017;46(1):18-25. doi: 10.1093/ageing/afw138, PMID 28181634.
Lipinski MJ, Escárcega RO, D’Ascenzo F, Magalhaes MA, Baker NC, Torguson R, Chen F, Epstein SE, Miro O, Llorens P, Giannitsis E, Lotze U, Lefebvre S, Sebbane M, Cristol JP, Chenevier Gobeaux C, Meune C, Eggers KM, Charpentier S, Twerenbold R, Mueller C, Biondi Zoccai G, Waksman R, Baker NC. A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am J Cardiol. 2014;113(9):1581-91. doi: 10.1016/j.amjcard. 2014.01.436, PMID 24731654.
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Crea F, Van de Werf F, Bucciarelli Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O’Gara PT, Fox KAA, Hasdai D, Aboyans V, Achenbach S, Agewall S, Alexander T, Avezum A, Barbato E, Bassand J, Bates E, Bittl JA, Breithardt G, Bueno H, Bugiardini R, Cohen MG, Dangas G, de Lemos JA, Delgado V, Filippatos G, Fry E, Granger CB, Halvorsen S, Hlatky MA, Ibanez B, James S, Kastrati A, Leclercq C, Mahaffey KW, Mehta L, Müller C, Patrono C, Piepoli MF, Piñeiro D, Roffi M, Rubboli A, Sharma S, Simpson IA, Tendera M, Valgimigli M, van der Wal AC, Windecker S, Chettibi M, Hayrapetyan H, Roithinger FX, Aliyev F, Sujayeva V, Claeys MJ, Smajić E, Kala P, Iversen KK, El Hefny E, Marandi T, Porela P, Antov S, Gilard M, Blankenberg S, Davlouros P, Gudnason T, Alcalai R, Colivicchi F, Elezi S, Baitova G, Zakke I, Gustiene O, Beissel J, Dingli P, Grosu A, Damman P, Juliebø V, Legutko J, Morais J, Tatu-Chitoiu G, Yakovlev A, Zavatta M, Nedeljkovic M, Radsel P, Sionis A, Jemberg T, Muller C, Abid L, Abaci A, Parkhomenko A, Corbett S. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-69. doi: 10.1093/eurheartj/ehy462.
Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev 2017(1):CD002003. doi: 10.1002/14651858.CD002003.pub5. PMID 17253471.
Larochelle P, Tobe SW, Lacourciere Y. β-Blockers in hypertension: studies and meta-analyses over the years. Can J Cardiol. 2014;30(5)Suppl:S16-22. doi: 10.1016/j.cjca.2014.02.012, PMID 24750978.
Wertli MM, Ruchti KB, Steurer J, Held U. Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis. BMC Med. 2013;11:239. doi: 10.1186/1741-7015-11-239, PMID 24207111.
Mussa FF, Horton JD, Moridzadeh R, Nicholson J, Trimarchi S, Eagle KA. Acute aortic dissection and intramural hematoma: a systematic review. JAMA. 2016;316(7):754-63. doi: 10.1001/jama.2016.10026, PMID 27533160.
Tomiyama H, Yamashina A. Beta-blockers in the management of hypertension and/or chronic kidney disease. Int J Hypertens. 2014;2014:1-7. doi: 10.1155/2014/919256, PMID 919256.
DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D’Ascenzo F, Cerrato E, Biondi Zoccai G, Lavie CJ, Bell DS, O’Keefe JH. β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart. 2015;2(1):e000230. doi: 10.1136/openhrt-2014-000230, PMID 25821584.
Rajapakse T, Pringsheim T. Nutraceuticals in migraine: a summary of existing guidelines for use. Headache. 2016;56(4):808-16. doi: 10.1111/head.12789, PMID 26954394.
British national formulary. BNF. Vol. 76. Pharmaceutical Press; 2018. p. 151-3.
Haggerty CL, Ness RB, Kelsey S, Waterer GW. The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol. 2003;90(3):284-91. doi: 10.1016/S1081-1206(10)61794-2. PMID 12669890.
Bhatia NM, Gavali AY. Development and validation of method for simultaneous estimation of atenolol and lercanidipine from tablet dosage form by second-order derivative spectroscopy. Asian J Res Chem. 2009;2:398-400.
Kaila HO, Ambasana MA, Thakkar RS, Saravaia HT, Shah AK. A stability-indicating high-performance liquid chromatographic assay for the simultaneous determination of atenolol and lercanidipine hydrochloride in tablets. Indian J Pharm Sci. 2011;73(4):376-80. doi: 10.4103/0250-474X.95612, PMID 22707819.
Gade R, Bandhakavi SR, Ganji R. Method development and validation of stability indicating RP-HPLC method for simultaneous estimation of atenolol and lercanidipine in bulk and its pharmaceutical formulations. Brahma Am J Adv Drug Deliv. 2014;2:752-66.
Bansode PS. Development and validation of lercanidipine hydrochloride and atenolol by using RP-HPLC and UV spectroscopy. Indian J Pharm Pharmacol. 2014;1:37-41.
Jain DK, Patel P, Khan AS, Jain N. Development and validation of a RP-HPLC method for the simultaneous estimation of atenolol and lercanidipine hydrochloride in pharmaceutical dosage forms. Int J Chem Technol Research. 2011;3:766-71.
Rafi S, Rambabu K. Bio-analytical method development and validation of avelumab, axitinib and its application to pharmacokinetic studies in rabbit plasma by using lcms/ms. Int J App Pharm. 2021;13:198-204. doi: 10.22159/ ijap.2021v13i5.42415.
Naveen VMK, Veeraswami B, Srinivasa Rao G. High response bio analytical validation approach of nadolol and bendroflumethiazide by LC-MS/MS on rat plasma. Int J Res Pharm Sci. 2021;12:1-8.
Bhavani P, Prasada Rao K, Mohan S. Novel validated reversed-phase high-performance liquid chromatography method for determination of glucosamine, diacerein, and methyl sulfonyl methane in micro-sample rat plasma and its application to pharmacokinetic and dissolution studies. Asian J Pharm Clin Res. 2020;13:50-63. doi: 10.22159/ajpcr.2020.v13i12.36547.
Naresh Kumar DS, Patel D. Stability indicating chromatographic method development and validation for the simultaneous estimation of escitalopram oxalate and flupentixol in its pharmaceutical dosage form by HPLC. WJPR. 2017;6:549-66.
Supriya T, Naresh D, Vijaya Kumar G, Haneer MA. Stability indicating RP-HPLC method development and validation for simultaneous estimation of escitalopram and flupentixol pure and marketed formulation. Asian J Pharm Res. 2018;8:4-10.
International conference on harmonization. ICH harmonized tripartite guideline. Validation of analytical procedures: text and methodology. Vol. Q2(R1); 2005.
Shivani CP, Maheshwari DG. Development and validation of UV spectrometric and HPLC method for estimation of escitalopram oxalate and flupentixol dihydrochloride in the combined dosage form. AJPTI. 2016;4:59-70.
Balaji Gupta VLN T, Venkateswara Rao B, Kishore Babu B. RP-HPLC (stability indicating) based assay method for the simultaneous estimation of doravirine, tenofovir disoproxil fumarate and lamivudine. Int J Appl Pharm. 2021;13:153-9.
Naykode MD, Bhagwat DA, Jadhav SD, More HN. Analytical and bioanalytical method for quantification of pure azilsartan, not its salts by RP-HPLC. Res J Pharm Technol. 2017;10(3):708-14. doi: 10.5958/0974-360X.2017.00133.0.
Singh M, Charde M, Shukla R, Rita MC. Determination of calcipotriene in calcipotriene cream 0.05% w/w by RP-HPLC method development and validation. Res J Pharm Technol. 2011;4:1219-23.
kumar AS, Manidipa Debnath, Seshagiri Rao JVLN, Gowri Sankar D. Development and validation of a sensitive RP-HPLC method for simultaneous estimation of rosuvastatin and fenofibrate in tablet dosage form by using PDA detector in gradient mode. Research J Pharm Tech. 2016;9:549-54.
Malathi S, Arunadevi N. Development and validation of stability-indicating simultaneous estimation of metformin and alogliptin in tablets by high-performance thin-layer chromatography. Int J Pharm Pharm Sci. 2020;12:68-73.
Ramadevi P, Rambabu K. Bioanalytical method development and validation for ezetimibe and pitavastatin and its application to pharmacokinetic studies in rabbit plasma by using LC-MS/MS. Int J Res Pharm Sci. 2021;11:7854-62.
Malak Y, Al-Bathish AA, Gazy MK El-Jamal. Rp-hplc and chemometric methods for the determination of two anti-diabetic mixtures; metformin hydrochloride-canagliflozin and metformin hydrochloride-gliclazide in their pharmaceutical formulation. Int J Pharm Pharm Sci. 2020;12:83-94.
Vijayakumari M, Reddy Ch B. Stability indicating validated hplc method for the determination of zanubrutinib in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. 2020;13:159-62.
Gomathy S, Narenderan ST, Meyyanathan SN, Gowramma B. Development and validation of hplc method for the simultaneous estimation of apigenin and luteolin in commercial formulation. Crit Rev. 2020;7:4785-90.
Yarlagadda SR, Mannam SR, Jampani BP. Stability indicating and cost-effective analytical method development and validation of sotorasib by using rp-hplc. Int J App Pharm. 2021;13:154-9. doi: 10.22159/ijap.2021v13i5.42659.
Ramachandran D, Kethipalli A, Mannam K. Bio-analytical method development and validation of daunorubicin and cytarabine in rat plasma by LC-MS/MS and its application in pharmacokinetic studies. J Pharm Sci Res. 2020;12:381-6.
Gadhvi MP, Bhandari A, Suhagia BN, Desai UH. Development and validation of RP-HPLC method for simultaneous estimation of atazanavir and ritonavir in their combined tablet dosage form. Res J Pharm Technol. 2013;6:200-3.
Senthil Rajan D, Muruganathan G, Shivkumar K, Ganesh T. Development and validation of hplc method for simultaneous quantification of vasicine, glycyrrhizin and piperine in poly herbal cough syrup. Int J Curr Pharm Res. 2020;12:15-9.
Rajakumari R, Sreenivasa Rao S. Stress degradation studies and development of a validated RP-HPLC method for determination of tiagabine in the presence of its degradation products. Int J Pharm Pharm Sci. 2016;8:230-6.
Charu Pandya P, Sadhana Rajput J. Development and validation of stability-indicating method RP-HPLC method of acotiamide. Int J Pharm Pharm Sci. 2018;10:1-8.
Athavia BA, Dedania ZR, Dedania RR, Swamy SMV, Prajapati CB. Stability indicating hplc method for determination of vilazodone hydrochloride. Int J Curr Pharm Sci 2017;9(4). doi: 10.22159/ijcpr.2017v9i4.20975.
Swati K, Abhishek P, Sushank S, Bothiraja C, Atmaram P. High-performance liquid chromatography for the simultaneous estimation of cefoperazone and sulbactam in rat plasma and its importance in therapeutic drug monitoring. Int J Pharm Pharm Sci. 2020;12:92-7.
Narasimha S, Lakka NS, Chandrasekar Kuppan C, Kona S, Srinivas KS, Raviteja Yarra R. Separation and characterization of new forced degradation products of dasatinib in tablet dosage formulation using LC–MS and stability-indicating HPLC methods. Chromatographia. 2020;83(8):947-62. doi: 10.1007/s10337-020-03920-0.
Chavan BB, Vijaya Jyothi P, Kalariya PD, Srinivas R, Talluri MVNK, Pradipbhai D Kalariya. Alcaftadine: selective separation and characterization of degradation products by LC-QTOF-MS/MS. Chromatographia. 2018;81(4):631-8. doi: 10.1007/s10337-018-3489-1.
Naykode MD, Bhagwat DA, Jadhav SD, More HN. Analytical and bioanalytical method for quantification of pure azilsartan, not its salts by RP-HPLC. Res J Pharm Technol. 2017;10(3):708-14. doi: 10.5958/0974-360X.2017.00133.0.
Published
How to Cite
Issue
Section
Copyright (c) 2022 P. T. S. R. K. PRASADA RAO
This work is licensed under a Creative Commons Attribution 4.0 International License.
